Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
2.
Catheter Cardiovasc Interv ; 80(1): 112-9, 2012 Jul 01.
Article in English | MEDLINE | ID: mdl-21953787

ABSTRACT

OBJECTIVES: The purpose of this study was to analyze the debris captured in the distal protection filters used during carotid artery stenting (CAS). BACKGROUND: CAS is an option available to high-risk patients requiring revascularization. Filters are suggested for optimal stroke prevention during CAS. METHODS: From May 2005 to June 2007, filters from 59 asymptomatic patients who underwent CAS were collected and sent to a specialized laboratory for light-microscope and histological analysis. Peri- and postprocedural outcomes were assessed during 1-year follow-up. RESULTS: On the basis of biomedical imaging of the filter debris, the captured material could not be identified as embolized particles from the carotid plaque. On histological analysis the debris consisted mainly of red blood cell aggregates and/ or platelets, occasionally accompanied by granulocytes. We found no consistent histological evidence of embolized particles originating from atherosclerotic plaques. Post-procedure, three neurological events were reported: two (3.4%) transient ischemic attacks (TIA) and one (1.7%) ipsilateral minor stroke. CONCLUSION: The filters used during CAS in asymptomatic patients planned for cardiac surgery often remained empty. These findings may be explained by assuming that asymptomatic patients feature a different atherosclerotic plaque composition or stabilization through antiplatelet medication. Larger, randomized trials are clearly warranted, especially in the asymptomatic population.


Subject(s)
Angioplasty/instrumentation , Carotid Artery Diseases/therapy , Coronary Artery Bypass , Coronary Artery Disease/surgery , Embolic Protection Devices , Embolism/prevention & control , Stents , Aged , Angioplasty/adverse effects , Asymptomatic Diseases , Carotid Artery Diseases/complications , Carotid Artery Diseases/diagnosis , Coronary Artery Bypass/adverse effects , Coronary Artery Disease/complications , Embolism/diagnosis , Embolism/etiology , Female , Humans , Ischemic Attack, Transient/etiology , Ischemic Attack, Transient/prevention & control , Male , Middle Aged , Prosthesis Design , Severity of Illness Index , Stroke/etiology , Stroke/prevention & control , Switzerland , Time Factors , Treatment Outcome , Ultrasonography, Doppler, Pulsed , Ultrasonography, Doppler, Transcranial
3.
Ann Thorac Surg ; 89(6): S2151-5, 2010 Jun.
Article in English | MEDLINE | ID: mdl-20494000

ABSTRACT

BACKGROUND: Endoscopic mucosal resection (EMR) is an appealing method for treating intramucosal esophageal cancer but must comply with the following stringent requirements: proper preoperative staging, complete resection of the lesion, obtaining a resected specimen for histologic analysis of safety margins, and squamous reepithelialization without stricture formation. METHODS: A rigid esophagoscope was created to resect up to 12 cm(2) of esophageal mucosa in a single specimen and at a constant depth through the submucosa. Under visual control, the esophageal mucosa is sucked into a transparent window and resected with a thin diathermy wire loop in 10 seconds. After extensive preclinical studies in a sheep model, this article reports our early experience in humans. RESULTS: Twenty-one hemi-circumferential EMRs were performed for 11 dysplastic Barrett's esophagi and 10 early squamous cell carcinomas with no perforation, one hemorrhage controlled by embolization of the left gastric artery, and one incomplete resection. Deep safety margins were clear in 19 of 21 resected specimens (2 patients, unfit for operations, had submucosal invasion of squamous cell carcinoma and adenocarcinoma, respectively). Lateral margins were not clear by definition in 7 circumferential Barrett's esophagi, but were clear in 4 incomplete Barrett's esophagi and 10 early squamous cell carcinomas. CONCLUSIONS: Large EMRs of 12 cm(2) can safely be performed at the submucosal level in the esophagus. Although feasible in one session, circumferential EMR in humans is not yet advisable because of the risk of stricture formation during the healing phase. The rate of complications of this series of 21 EMRs in humans is acceptable.


Subject(s)
Carcinoma in Situ/surgery , Carcinoma, Squamous Cell/surgery , Esophageal Neoplasms/surgery , Esophagoscopy/methods , Aged , Carcinoma in Situ/pathology , Carcinoma, Squamous Cell/pathology , Equipment Design , Esophageal Neoplasms/pathology , Esophagoscopes , Humans , Middle Aged , Mucous Membrane/surgery , Neoplasm Staging
SELECTION OF CITATIONS
SEARCH DETAIL
...